The Sociodemographic Factors Associated With Multimorbidity In Patients With Diabetes Mellitus Type 2 In District Hospital Sukoharjo Central Java.
DOI:
https://doi.org/10.47701/icohetech.v5i1.4140Keywords:
sociodemographic factors, multimorbidity, diabetes mellitus type 2Abstract
Background: Multiple chronic diseases known as multimorbidity are one of the global public health challenges. Multimorbidity among older adults was more than 50% in different countries. This study aimed to analyze the sociodemographic factors associated with multimorbidity in patients with diabetes mellitus type 2 in District Hospital Sukoharjo Central Java.
Methods: This study used a cross-sectional approach utilizing medical record data of diabetes mellitus patients. Consecutive sampling was conducted, and 75 samples were included. A descriptive analysis was performed by reporting percentages. Bivariate analysis was conducted using Chi-square. Logistic regression with a 5% significance level was used to analyze the multivariable.
Results: The prevalence of multimorbidity was 33 (44%). The sociodemographic factors associated with multimorbidity were age (p=0.039), gender (p=0.032), education (p=0.028), status of employment (p=0.020), and length of stay (p=0.011). Logistic regression showed an association between length of stay (OR=3.93;95%CI=1.29-11,92; p=0.016) and multimorbidity.
Conclusion: Based on these findings, the sociodemographic factors associated with multimorbidity in patients with diabetes mellitus type 2 were: age, gender, education, status of employment, and length of stay. The programs to prevent multimorbidity should be formulated. Early detection and health promotion can be managed to decrease multimorbidity in patients with diabetes mellitus type 2.
References
Cassell, A., Edwards, D., Harshfield, A., Rhodes, K., Brimicombe, J., Payne, R., & Griffin, S. (2018). The epidemiology of multimorbidity in primary care. British Journal of General Practice, 68(669), 1–7. http://bjgp.org/content/early/2018/03/12/bjgp18X695465
Cicek, M., Buckley, J., Pearson-Stuttard, J., & Gregg, E. W. (2021). Characterizing Multimorbidity from Type 2 Diabetes: Insights from Clustering Approaches. Endocrinology and Metabolism Clinics of North America, 50(3), 531–558. https://doi.org/10.1016/j.ecl.2021.05.012
Costa, Â. K., Bertoldi, A. D., Fontanella, A. T., Ramos, L. R., Arrais, P. S. D., Luiza, V. L., Mengue, S. S., & Nunes, B. P. (2020). Does socioeconomic inequality occur in the multimorbidity among Brazilian adults? Revista de Saude Publica, 54, 138. https://doi.org/10.11606/s1518-8787.2020054002569
Griselda, M., Alfian, S. D., Wicaksono, I. A., Wawruch, M., & Abdulah, R. (2023). Findings from the Indonesian family life survey on patterns and factors associated with multimorbidity. Scientific Reports, 13(1), 1–16. https://doi.org/10.1038/s41598-023-42603-2
Husnayain, A., Ekadinata, N., Sulistiawan, D., & Su, E. C. Y. (2020). Multimorbidity patterns of chronic diseases among indonesians: Insights from indonesian national health insurance (inhi) sample data. International Journal of Environmental Research and Public Health, 17(23), 1–12. https://doi.org/10.3390/ijerph17238900
Ioakeim-Skoufa, I., Poblador-Plou, B., Carmona-Pírez, J., Díez-Manglano, J., Navickas, R., Gimeno-Feliu, L. A., González-Rubio, F., Jureviciene, E., Dambrauskas, L., Prados-
Torres, A., & Gimeno-Miguel, A. (2020). Multimorbidity patterns in the general population: Results from the epichron cohort study. International Journal of Environmental Research and Public Health, 17(12), 1–15. https://doi.org/10.3390/ijerph17124242
Khan, M. R., Malik, M. A., Akhtar, S. N., Yadav, S., & Patel, R. (2022). Multimorbidity and its associated risk factors among older adults in India. BMC Public Health, 22(1), 1–8. https://doi.org/10.1186/s12889-022-13181-1
Khunti, K., Chudasama, Y. V., Gregg, E. W., Kamkuemah, M., Misra, S., Suls, J., Venkateshmurthy, N. S., & Valabhji, J. (2023). Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge. Diabetes Care, 46(12), 2092–2101. https://doi.org/10.2337/dci23-0035
Myint, C. Y., Pavlova, M., Thein, K. N. N., & Groot, W. (2019). A systematic review of the health-financing mechanisms in the association of southeast asian nations countries and the people’s Republic of China: Lessons for the move towards universal health coverage. PLoS ONE, 14(6), 1–18. https://doi.org/10.1371/journal.pone.0217278
Navickas, R., Petric, V.-K., Feigl, A. B., & Seychell, M. (2016). Multimorbidity: What Do We Know? What Should We Do? Journal of Comorbidity, 6(1), 4–11. https://doi.org/10.15256/joc.2016.6.72
Patcharanarumol, W., Panichkriangkrai, W., Sommanuttaweechai, A., Hanson, K., Wanwong, Y., & Tangcharoensathien, V. (2018). Strategic purchasing and health system efficiency: A comparison of two financing schemes in Thailand. PLoS ONE, 13(4). https://doi.org/10.1371/journal.pone.0195179
Pearson-Stuttard, J., Holloway, S., Polya, R., Sloan, R., Zhang, L., Gregg, E. W., Harrison, K., Elvidge, J., Jonsson, P., & Porter, T. (2022). Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence. EClinicalMedicine, 52(Dm), 101584. https://doi.org/10.1016/j.eclinm.2022.101584
Picco, L., Achilla, E., Abdin, E., Chong, S. A., Vaingankar, J. A., McCrone, P., Chua, H. C., Heng, D., Magadi, H., Ng, L. L., Prince, M., & Subramaniam, M. (2016). Economic burden of multimorbidity among older adults: Impact on healthcare and societal costs. BMC Health Services Research, 16(1), 1–12. https://doi.org/10.1186/s12913-016-1421-7
Sinha, A., Suman, S. S., Subedi, N., Sahoo, K. C., Poudel, M., Chauhan, A., Sahoo, B., Akker, M. Van Den, & Weller, D. (2024). Epidemiology of multimorbidity in Nepal?: A systematic review and meta-analysis. 14, 1–10. https://doi.org/10.1177/26335565241284022
Stokes, J., Guthrie, B., Mercer, S. W., Rice, N., & Sutton, M. (2021). Multimorbidity combinations, costs of hospital care and potentially preventable emergency admissions in England: A cohort study. PLoS Medicine, 18(1), 1–16. https://doi.org/10.1371/journal.pmed.1003514
Suls, J., Green, P. A., & Boyd, C. M. (2020). Multimorbidity Implications and Directions for Health.pdf. Physiology & Behavior, 176(3), 139–148. https://doi.org/10.1037/hea0000762.Multimorbidity
Valderas, J. M., Gangannagaripalli, J., Nolte, E., Boyd, C. M., Roland, M., Sarria-Santamera, A., Jones, E., & Rijken, M. (2019). Quality of care assessment for people with multimorbidity. Journal of Internal Medicine, 285(3), 289–300. https://doi.org/10.1111/joim.12881
Varanasi, R., Sinha, A., Bhatia, M., Nayak, D., Manchanda, R. K., Janardhanan, R., Lee, J. T., Tandon, S., & Pati, S. (2024). Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis. Journal of Multimorbidity and Comorbidity, 14(August), 1–18. https://doi.org/10.1177/26335565241258851
